CSIMarket
 
Amylyx Pharmaceuticals Inc   (AMLX)
Other Ticker:  
 
 

Amylyx Pharmaceuticals Inc Balance Sheet Quarterly

AMLX


Select the Financial Report:   Period:   Fiscal Year:




AMLX Balance Sheets
(Quarterly, GAAP in millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
ASSETS
Cash & cash equivalent 135.26 247.76 114.56 62.53 107.73
Cash, Cash Eqvivalents Other - - - - -
Short-term Investments, Total 219.79 109.52 231.11 284.42 54.86
Cash & Short-term Investments 355.05 357.28 345.67 346.95 162.59
Accounts receivable 29.35 33.47 17.56 15.31 0.14
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Inventories 32.37 24.86 13.08 9.77 0.56
Deferred Offering Costs DE - - - - 0.57
Other Current Assets - - - - 0.00
Prepaid Expense And Other Assets Current 17.34 11.79 12.75 10.11 8.34
Total Current Assets 434.11 427.39 389.05 382.13 172.20
Equipment/Property/Plant Net 2.76 2.64 2.56 2.61 2.12
Goodwill net - - - - -
Intangible Assets - - - - -
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 26.00 20.00 11.00 2.00 2.00
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Restricted Cash Noncurrent - - - - 0.72
Operating Lease Right Of Use Asset 4.19 4.64 5.09 5.52 5.95
Total Assets 466.58 453.59 407.96 391.45 181.44
LIABILITIES
Accounts Payable, Current AC 6.37 24.70 10.77 6.26 7.05
Accrued Liabilities, Current AC 37.05 37.24 38.75 38.31 23.61
Financial Instruments - - - - -
Shortterm Debt - - - - -
Other Liabilities, Current 2.20 2.15 2.09 2.04 1.99
Taxes Payable - - - - -
Deferred Liability and Revenue - - - - -
Discontinued Operation, Liabilities, Current - - - - -
Operating Lease Liability Current 2.20 2.15 2.09 2.04 1.99
Operating Lease Liability Noncurrent 2.57 3.14 3.69 4.24 4.77
Total Current Liabilities 45.62 64.08 51.62 46.61 32.65
Long-term debt - - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 2.57 3.14 3.69 4.24 4.77
Total Liabilities 48.18 67.22 55.31 50.85 37.42
SHAREHOLDER'S EQUITY
Common Stock Value 0.01 0.01 0.01 0.01 0.01
Additional Paid In Capital Common Stock 728.22 717.00 705.26 694.91 456.26
Retained Earnings / Accumulated Deficit -309.68 -330.57 -352.65 -354.22 -311.52
Other Equity -0.15 -0.07 0.03 -0.09 -0.72
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 418.40 386.37 352.65 340.61 144.03
Liabilities & Stockholder's Equity 466.58 453.59 407.96 391.45 181.44






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com